We are live on ! Find out more
DAM

Doheny Asset Management Portfolio holdings

AUM $153M
1-Year Est. Return 42.04%
This Fund
S&P 500
This Quarter Est. Return
+4.7%
1 Year Est. Return
+42.04%
3 Year Est. Return
+121.4%
5 Year Est. Return
10 Year Est. Return
AUM
$184M
AUM Growth
-$6.02M
Cap. Flow
-$10.5M
Cap. Flow %
-5.67%
Top 10 Hldgs %
39.53%
Holding
108
New
5
Increased
12
Reduced
54
Closed
8

Top Sells

Rank Stock Value
1
AIMT
Aimmune Therapeutics
AIMT
+$2.64M
2
NMRK icon
Newmark Group
NMRK
+$2.07M
3
SBUX icon
Starbucks
SBUX
+$2M
4
KYNB
Kyntra Bio
KYNB
+$1.7M
5
AAPL icon
Apple
AAPL
+$1.26M

Sector Composition

Rank Sector Weight
1 Technology 24.88%
2 Healthcare 14.44%
3 Energy 14%
4 Financials 12.58%
5 Real Estate 10.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHW
26
Charles Schwab
SCHW
$183B
$2.29M 1.24%
44,875
-3,025
-6% -$168K
COP icon
27
ConocoPhillips
COP
$147B
$2.17M 1.18%
31,215
SEI
28
Solaris Energy Infrastructure
SEI
$3.15B
$2.07M 1.12%
+144,950
New +$2.41M
RWT
29
Redwood Trust
RWT
$574M
$2.04M 1.1%
123,617
-8,500
-6% -$136K
PFE icon
30
Pfizer
PFE
$143B
$1.93M 1.05%
56,077
SBUX icon
31
Starbucks
SBUX
$120B
$1.86M 1.01%
38,185
-35,255
-48% -$2M
STZ icon
32
Constellation Brands
STZ
$22.2B
$1.77M 0.96%
8,095
+4,140
+105% +$935K
AXP icon
33
American Express
AXP
$227B
$1.71M 0.93%
17,441
+12,805
+276% +$1.26M
NVDA icon
34
NVIDIA
NVDA
$4.86T
$1.53M 0.83%
257,680
-15,200
-6% -$92.3K
HAL icon
35
Halliburton
HAL
$26.9B
$1.52M 0.83%
33,776
-4,400
-12% -$219K
GILD icon
36
Gilead Sciences
GILD
$162B
$1.46M 0.79%
20,671
-14,335
-41% -$1.01M
ADI icon
37
Analog Devices
ADI
$179B
$1.45M 0.79%
15,126
-1,500
-9% -$142K
ANH
38
DELISTED
Anworth Mortgage Asset Corporation
ANH
$1.44M 0.78%
290,000
-44,300
-13% -$217K
MDLZ icon
39
Mondelez International
MDLZ
$79.5B
$1.42M 0.77%
34,696
-1,650
-5% -$66.3K
SNR
40
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$1.3M 0.71%
172,000
-73,500
-30% -$584K
LMT icon
41
Lockheed Martin
LMT
$134B
$1.27M 0.69%
4,305
-1,385
-24% -$447K
XOM icon
42
ExxonMobil
XOM
$644B
$1.27M 0.69%
15,318
+1,225
+9% +$97.6K
C icon
43
Citigroup
C
$222B
$1.26M 0.68%
18,775
-6,650
-26% -$458K
EWBC icon
44
East-West Bancorp
EWBC
$17.9B
$1.24M 0.67%
19,000
-275
-1% -$18.6K
AMGN icon
45
Amgen
AMGN
$208B
$1.21M 0.66%
6,571
-800
-11% -$142K
PEP icon
46
PepsiCo
PEP
$190B
$1.13M 0.61%
10,370
-300
-3% -$31K
AMZN icon
47
Amazon
AMZN
$2.92T
$1.07M 0.58%
12,640
-3,360
-21% -$267K
MU icon
48
Micron Technology
MU
$930B
$998K 0.54%
19,030
-18,045
-49% -$976K
CELG
49
DELISTED
Celgene Corp
CELG
$993K 0.54%
12,504
-11,726
-48% -$974K
KHC icon
50
Kraft Heinz
KHC
$30.7B
$992K 0.54%
15,799
-1,000
-6% -$59.3K

Similar funds

Doheny Asset Management's Q2 2018 Portfolio in Review

As of Q2 2018, Doheny Asset Management held 108 positions worth $184M, down 3.2% from $190M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Doheny Asset Management withdrew a net $10.5M in Q2 2018, closing 8 positions and reducing 54 holdings. Its most notable exit was Aimmune Therapeutics, an estimated $2.64M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Doheny Asset Management opened a new position in Solaris Energy Infrastructure worth $2.07M.

  • Doheny Asset Management's largest Q2 2018 buy was Solaris Energy Infrastructure: 144,950 shares worth $2.07M.
  • Doheny Asset Management added most to Resonant Inc. in Q2 2018, an estimated $2.47M increase.
  • Doheny Asset Management's biggest Q2 2018 reduction was Newmark Group, cutting an estimated $2.07M.
  • Doheny Asset Management fully exited Aimmune Therapeutics in Q2 2018, selling an estimated $2.64M.
  • Doheny Asset Management's ten largest holdings make up 40% of its $184M portfolio in Q2 2018.
  • Doheny Asset Management opened 5 new positions and closed 8 in Q2 2018.
  • Doheny Asset Management's portfolio value fell 3.2% quarter-over-quarter to $184M.

Based on Doheny Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.